GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes
Open accessThe DOI matches its OpenAlex record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Insulin-dependent type 1 diabetes is an autoimmune disease mediated by T lymphocytes recognizing pancreatic islet cell antigens. Glutamic acid decarboxylase 65 (GAD65) appears to be an important autoantigen in the disease. However, T cells from both patients with type 1 diabetes and healthy subjects vigorously proliferate in response to GAD65 stimulation ex vivo, leading us to postulate that the critical event in the onset of human diabetes is the activation of autoreactive T cells. Thus, we investigated whether GAD65-reactive T cells in patients with diabetes functioned as previously activated memory T cells, no longer requiring a second, costimulatory signal for clonal expansion. We found that in patients with new-onset type 1 diabetes, GAD65-reactive T cells were strikingly less dependent on CD28 and B7-1 costimulation to enter into cell cycle and proliferate than were equivalent cells derived from healthy controls. We hypothesize that these autoreactive T cells have been activated in vivo and have differentiated into memory cells, suggesting a pathogenic role in type 1 diabetes. In addition, we observed different effects with selective blockade of either B7-1 or B7-2 molecules; B7-1 appears to deliver a negative signal by engaging CTLA-4, while B7-2 engagement of CD28 upregulates T cell proliferation and cytokine secretion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914 · cited 1×
“Similarly, mice that had disruption of the CTLA-4 gene develop a lymphoproliferative disorder leading to a massive lymphocyte infiltration of different organs and to early death (44).”
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel, M. F., & Allison, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.459 · Cited by 2,245 · cited 1×
“CTLA-4 is a CD28 homologue expressed on activated T cells that binds with high affinity to B7-1 and B7-2 (35, 36) and functions as a negative regulator of T cell activation (37, 38).”
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222 · cited 2×
“CTLA-4 is a CD28 homologue expressed on activated T cells that binds with high affinity to B7-1 and B7-2 (35, 36) and functions as a negative regulator of T cell activation (37, 38).”
A cell culture model for T lymphocyte clonal anergy
Schwartz, R. H. (1990) · Science · doi:10.1126/science.2113314 · Cited by 1,857
CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685 · cited 7×
“Considering the differences we observed between B7-1 versus B7-2 blockade, it was of interest to investigate further the specific interactions of B7-1 and B7-2 with their counter-receptors, CD28 and CTLA-4.”
InfluentialEisenbarth (1986) · doi:10.1056/nejm198605223142106 · Cited by 1,659 · cited 2×
“Type 1a or insulin-dependent diabetes mellitus (IDDM) is the result of a progressive T cell–mediated autoimmune destruction of insulin-producing β cells in the pancreatic islets of Langherans (1).”
Cited by
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Self-citationVoltage-gated potassium channels as therapeutic targets
Wulff, H., Castle, N. A., & Pardo, L. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2983 · Cited by 799
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis
Bien, C. G., Vincent, A., Barnett, M. H., Becker, A. J., Blumcke, I., Graus, F., Jellinger, K. A., Reuss, D. E., Ribalta, T., Schlegel, J., et al. (2012) · Brain · doi:10.1093/brain/aws082 · Cited by 695
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Beeton, C., Wulff, H., Standifer, N. E., Azam, P., Mullen, K. M., Pennington, M. W., Kolski-Andreaco, A., Wei, E., Grino, A., Counts, D. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605136103 · Cited by 538
The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
Wulff, H., Calabresi, P. A., Allie, R., Yun, S., Pennington, M., Beeton, C., & Chandy, K. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16921 · Cited by 422
Gotter, J., Brors, B., Hergenhahn, M., & Kyewski, B. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031677 · Cited by 359
Autoreactive T cells in type 1 diabetes
Pugliese, A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94549 · Cited by 358
Self-representation in the thymus: an extended view
Kyewski, B., & Derbinski, J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1436 · Cited by 342
Human regulatory T cells and their role in autoimmune disease
Baecher‐Allan, C., & Hafler, D. A. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00417.x · Cited by 266
Self-citationHLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease
Tollefsen, S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27620 · Cited by 214
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
Chi, V., Pennington, M. W., Norton, R. S., Tarcha, E. J., Londono, L. M., Sims-Fahey, B., Upadhyay, S. K., Lakey, J. T., Iadonato, S., Wulff, H., et al. (2012) · Toxicon · doi:10.1016/j.toxicon.2011.07.016 · Cited by 213
“Disease-associated autoreactive T cells in patients with MS (specific for myelin antigens), T1DM (specific for insulin and GAD65 antigens), RA (synovial T cells) or psoriasis are TEM-effector cells (Beeton et al., 2006; Fasth et al., 2004; Friedrich et al., 2000; Lovett-Racke et al., 1998; Miyazaki et al., 2008; Rus e…”
Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis—A Systematic Analysis
Blinder, T., & Lewerenz, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00804 · Cited by 195
Kv1.3 potassium channels as a therapeutic target in multiple sclerosis
Rangaraju, S., Chi, V., Pennington, M. W., & Chandy, K. G. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903018957 · Cited by 99
Metadata
- Authors
- Viglietta, V., Kent, S. C., Orban, T., & Hafler, D. A.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2002-04-01
- Volume
- 109
- Issue
- 7
- Pages
- 895-903
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2133088091
- Cited by
- 170
- References
- 6
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.